Home
  • The Future of Bioelectronic Medicine

    July 8, 2016 – Kevin J. Tracey, a neurosurgeon and inventor, is the president and CEO of the Feinstein Institute for Medical Research. ‘Once we realized the power of the immune system to cause damage, then the question is: Can we use the nervous system to turn off the damage?’ he asks.
    Read More
     
  • SetPoint Announces $15 Million Equity Financing, Adds Major Strategic Investor

    September 8, 2015 – SetPoint Medical, a biomedical technology company developing a bioelectronic therapy for inflammatory diseases, announced today that it has secured $15 million in an extension to its Series C equity financing, bringing the total raised in this round to $43 million. Proceeds from the financing will be used to support the company’s clinical trials to assess safety and efficacy of its bioelectronic therapy in rheumatoid arthritis (RA) and Crohn’s Disease, and to help advance the therapy toward commercialization.
    Read More
     
  • SetPoint Announces First Trial of Bioelectronic Therapy to Treat Crohn's Disease

    December 4, 2014 – SetPoint Medical, a biomedical technology company developing a bioelectronic medicine therapy for inflammatory diseases, announced today the start of clinical testing to assess safety and efficacy in Crohn's Disease, a debilitating disease caused by inflammation in the digestive tract. The trial launched as gastroenterologists gather this week in Orlando, Florida for "Advances in Inflammatory Bowel Diseases," the Crohn's & Colitis Foundation's annual clinical and research conference.
    Read More
     
  • The New York Times - Can the Nervous System Be Hacked?

    May 23, 2014 – One morning in May 1998, Kevin Tracey converted a room in his lab at the Feinstein Institute for Medical Research in Manhasset, N.Y., into a makeshift operating theater and then prepped his patient — a rat — for surgery. A neurosurgeon, and also Feinstein Institute’s president, Tracey had spent more than a decade searching for a link between nerves and the immune system. His work led him to hypothesize that stimulating the vagus nerve with electricity would alleviate harmful inflammation. "The vagus nerve is behind the artery where you feel your pulse," he told me recently, pressing his right index finger to his neck.
    Read More
     
  • The World's Top 10 Most Innovative Companies in Healthcare

    February 13, 2014 – For creating a built-in pain-relief platform. Some of the most chronic diseases--such as rheumatoid arthritis, diabetes, and multiple sclerosis--are due to some form of inflammation. SetPoint's technology consists of a tiny implant in the vagus nerve of the neck that, when activated, helps reduce the inflammatory reflex--the physiological response that controls inflammation--via a pathway discovered by the company's cofounder. SetPoint Medical, whose aim is to offer cheaper and less risky therapies for inflammatory diseases, is currently involved in clinical trials.
    Read More
     

Get To Know The Management

Anthony Arnold
CEO
Mike Faltys
CTO
Ralph Zitnik, MD
CMO
Allan Will
Chairman
 

S5 Box

Login

Register

*
*
*
*
*
*

Fields marked with an asterisk (*) are required.